https://www.selleckchem.com/products/Axitinib.html
profiles. Combination of different first-line treatments for erectile dysfunction (ED) has emerged as a promising therapeutic approach. To conduct the first double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of combination therapy with low-intensity shockwave therapy (LiST) and tadalafil vs LiST and placebo in patients with mild or mild-to-moderate vasculogenic ED. Fifty sexually active patients fulfilling the eligibility criteria were randomly assigned to 6 sessions of LiST twice weekly for
Curtir
Comentario
Compartilhar
